552-02
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 552-02, covering 2009-01-14 to 2018-09-18. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome [Phase 2]